CNBX Pharmaceuticals Inc. (OTCMKTS:CNBX) Sees Significant Decrease in Short Interest

CNBX Pharmaceuticals Inc. (OTCMKTS:CNBX) saw a large decrease in short interest during the month of October. As of October 31st, there was short interest totalling 7,500 shares, a decrease of 11.8% from the October 15th total of 8,500 shares. Based on an average daily volume of 280,100 shares, the days-to-cover ratio is currently 0.0 days.

CNBX Pharmaceuticals Price Performance

OTCMKTS CNBX remained flat at $0.01 during mid-day trading on Friday. 838 shares of the company were exchanged, compared to its average volume of 187,155. CNBX Pharmaceuticals has a fifty-two week low of $0.01 and a fifty-two week high of $0.02. The company has a 50 day moving average of $0.01 and a 200 day moving average of $0.01.

About CNBX Pharmaceuticals

CNBX Pharmaceuticals Inc, a clinical stage company, engages in the discovery, development, and commercialization of novel cannabinoid-based products and technologies for the treatment of cancer. Its lead product candidate is Cannabics SR, an oral capsule developed for the treatment of patients with advanced cancer and cancer anorexia cachexia syndrome.